Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

ABPI formalises links with clinical fraud investigation firm

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 264 No 7088p426
March 18, 2000 News

ABPI formalises links with clinical fraud investigation firm

The Association of the British Pharmaceutical Industry has formalised its relationship with a company that investigates fraud in clinical trials.
Medicolegal Investigations Ltd (MLI), founded by a former ABPI medical director (Dr Frank Wells) and Mr Peter Jay, a former detective chief inspector with the Metropolitan Police, now has a chairman and another director nominated by the ABPI. The new chairman is Mr Michael Wallace (vice-president, ABPI); the new director is Dr Richard Tiner (medical director, ABPI).
In a press statement on March 9, Dr Wells said: "Fraud in clinical trials is rare, but the realignment of MLI sends a clear message to doctors that they must adhere to rigorous ethical standards when participating in clinical trials."
MLI now intends to widen its remit from the investigation of clinical trials fraud to include a number of new services. These include: fraud awareness training; interview technique; random audits; private sector investigations; a whistleblowing service; and disciplinary investigations.

Citation: The Pharmaceutical Journal URI: 20000858

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.